Publications

9 items matching your search terms.

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer

Meyer, B.; Clifton, S.; Locke, W.; Luu, P. L.; Du, Q.; Lam, D.; Armstrong, N. J.; Kumar, B.; Deng, N.; Harvey, K.; Swarbrick, A.; Ganju, V.; Clark, S. J.; Pidsley, R.; Stirzaker, C.

Clinical Epigenetics 13 (1) :226, 2021 10.1186/s13148-021-01210-6

DNA methylation is required to maintain both DNA replication timing precision and 3D genome organization integrity

Du, Q.; Smith, G. C.; Luu, P. L.; Ferguson, J. M.; Armstrong, N. J.; Caldon, C. E.; Campbell, E. M.; Nair, S. S.; Zotenko, E.; Gould, C. M.; Buckley, M.; Chia, K. M.; Portman, N.; Lim, E.; Kaczorowski, D.; Chan, C. L.; Barton, K.; Deveson, I. W.; Smith, M. A.; Powell, J. E.; Skvortsova, K.; Stirzaker, C.; Achinger-Kawecka, J.; Clark, S. J.

Cell Reports 36 (12) :109722, 2021 10.1016/j.celrep.2021.109722

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer

Achinger-Kawecka, J.; Valdes-Mora, F.; Luu, P. L.; Giles, K. A.; Caldon, C. E.; Qu, W.; Nair, S.; Soto, S.; Locke, W. J.; Yeo-Teh, N. S.; Gould, C. M.; Du, Q.; Smith, G. C.; Ramos, I. R.; Fernandez, K. F.; Hoon, D. S.; Gee, J. M. W.; Stirzaker, C.; Clark, S. J.

Nature Communications 11 (1) :320, 2020 10.1038/s41467-019-14098-x

Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains

Khoury, A.; Achinger-Kawecka, J.; Bert, S. A.; Smith, G. C.; French, H. J.; Luu, P. L.; Peters, T. J.; Du, Q.; Parry, A. J.; Valdes-Mora, F.; Taberlay, P. C.; Stirzaker, C.; Statham, A. L.; Clark, S. J.

Nature Communications 11 (1) :54, 2020 10.1038/s41467-019-13753-7

Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups

Giles, K. A.; Gould, C. M.; Du, Q.; Skvortsova, K.; Song, J. Z.; Maddugoda, M. P.; Achinger-Kawecka, J.; Stirzaker, C.; Clark, S. J.; Taberlay, P. C.

Epigenetics & Chromatin 12 (1) :12, 2019 10.1186/s13072-019-0258-9

DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns

Skvortsova, K.; Masle-Farquhar, E.; Luu, P. L.; Song, J. Z.; Qu, W.; Zotenko, E.; Gould, C. M.; Du, Q.; Peters, T. J.; Colino-Sanguino, Y.; Pidsley, R.; Nair, S. S.; Khoury, A.; Smith, G. C.; Miosge, L. A.; Reed, J. H.; Kench, J. G.; Rubin, M. A.; Horvath, L.; Bogdanovic, O.; Lim, S. M.; Polo, J. M.; Goodnow, C. C.; Stirzaker, C.; Clark, S. J.

CANCER CELL 35 (2) :297-314 e8, 2019 10.1016/j.ccell.2019.01.004

Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer

Du, Q.; Bert, S. A.; Armstrong, N. J.; Caldon, C. E.; Song, J. Z.; Nair, S. S.; Gould, C. M.; Luu, P. L.; Peters, T.; Khoury, A.; Qu, W.; Zotenko, E.; Stirzaker, C.; Clark, S. J.

Nature Communications 10 (1) :416, 2019 10.1038/s41467-019-08302-1

Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer

Stirzaker, C.; Song, J. Z.; Ng, W.; Du, Q.; Armstrong, N. J.; Locke, W. J.; Statham, A. L.; French, H.; Pidsley, R.; Valdes-Mora, F.; Zotenko, E.; Clark, S. J.

ONCOGENE 36 (10) :1328-1338, 2017 10.1038/onc.2016.297

Methyl-CpG-binding domain proteins: readers of the epigenome

Du, Q. ; Luu, P. L. ; Stirzaker, C. ; Clark, S. J.;

Epigenomics :1-23, 2015